CALANDRA BUONAURA, Sebastiano
 Distribuzione geografica
Continente #
NA - Nord America 13.002
EU - Europa 5.509
AS - Asia 1.892
SA - Sud America 72
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 20.500
Nazione #
US - Stati Uniti d'America 12.957
GB - Regno Unito 2.159
IT - Italia 1.052
SE - Svezia 740
SG - Singapore 723
CN - Cina 597
DE - Germania 418
UA - Ucraina 318
HK - Hong Kong 230
FI - Finlandia 189
FR - Francia 182
TR - Turchia 180
RU - Federazione Russa 149
BG - Bulgaria 138
ID - Indonesia 54
BE - Belgio 49
BR - Brasile 47
IN - India 45
IE - Irlanda 31
NL - Olanda 31
CA - Canada 21
BZ - Belize 17
IR - Iran 17
CH - Svizzera 12
CZ - Repubblica Ceca 9
AR - Argentina 8
EU - Europa 8
JP - Giappone 7
MY - Malesia 7
PL - Polonia 7
LT - Lituania 6
VN - Vietnam 6
ES - Italia 5
TW - Taiwan 5
IL - Israele 4
MX - Messico 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CO - Colombia 3
EC - Ecuador 3
KG - Kirghizistan 3
PE - Perù 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CL - Cile 2
CU - Cuba 2
DZ - Algeria 2
EG - Egitto 2
KR - Corea 2
NZ - Nuova Zelanda 2
RO - Romania 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 20.500
Città #
Southend 1.865
Fairfield 1.752
Santa Clara 1.540
Woodbridge 1.212
Houston 980
Ashburn 880
Chandler 750
Jacksonville 740
Seattle 688
Ann Arbor 610
Wilmington 596
Cambridge 543
Nyköping 458
Singapore 454
Dearborn 445
Hong Kong 228
Modena 203
San Diego 150
Beijing 149
Princeton 148
Sofia 134
Eugene 115
Milan 107
Des Moines 89
Izmir 87
Grafing 82
Helsinki 82
Rome 76
New York 74
Moscow 61
London 57
Shanghai 52
Falls Church 49
Jakarta 49
Brussels 41
Bremen 38
San Jose 37
Boardman 33
Los Angeles 32
Naples 32
Dublin 29
Redwood City 28
Norwalk 26
San Mateo 22
Nanjing 20
Turin 18
Belize City 17
Dallas 16
Hefei 15
Leawood 15
Bologna 14
Kilburn 14
Kunming 14
Augusta 13
Chiswick 13
Hounslow 13
Indiana 13
Palermo 13
Parma 13
Chicago 12
Guangzhou 12
Florence 10
Jinan 10
Saint Louis 10
Toronto 10
Brescia 9
Paris 9
Reggio Emilia 9
Saint Petersburg 9
San Francisco 9
Verona 9
Acton 8
Ardabil 8
Brno 8
Frankfurt am Main 8
Fremont 8
Padova 8
Auburn Hills 7
Bartlesville 7
Islington 7
Prescot 7
Southwark 7
Washington 7
Munich 6
Waanrode 6
Atlanta 5
Catania 5
Guishan 5
Hebei 5
Ningbo 5
Piacenza 5
San Giorgio Ionico 5
Xian 5
Zhengzhou 5
Amsterdam 4
Ascoli Piceno 4
Benevento 4
Cagliari 4
Casalnuovo di Napoli 4
Changsha 4
Totale 16.333
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 814
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 399
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 234
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 233
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region. 226
Altered mRNA splicing in lipoprotein disorders. 225
A 'de novo' point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 220
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 219
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 215
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 213
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 207
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 204
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 202
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 202
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 201
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred. 196
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 195
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 194
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. 193
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 193
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. 190
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 188
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 188
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 188
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 188
MOLECULAR CHARACTERIZATION OF TWO PATIENTS WITH SEVERE LCAT DEFICIENCY 185
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia. 185
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 183
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 183
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 179
A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 179
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease 178
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 177
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 176
An apparent inconsistency in parent to offspring transmission ofpoint mutations of LDLR gene in familial hypercholesterolemia 175
Functional lecithin: Cholesterol acyltransferase Is not required for efficient atheroprotection in humans 175
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 173
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 173
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients 170
Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity 170
Preemptive liver transplantation in a child with familial hypercholesterolemia 170
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia 170
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 168
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 168
Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency 168
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 168
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 167
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy 165
Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia 164
Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes 163
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 163
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 162
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 161
Rearrangements of the ABCC6 gene in Italian patients with PXE 160
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 160
Severe HDL deficiency due to novel defects in the ABCA1 transporter 158
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 158
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 158
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). 158
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 158
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 158
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 157
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 155
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 155
Changes of the main isoform of human apolipoprotein A-I following incubation of plasma. 151
Cholesterol synthesis in freshly isolated human leukocytes. 149
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. 149
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 148
Plasma lipoproteins in rats with experimental biliary obstruction. I. A chemical study. 148
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 147
Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. 146
Synthesis and secretion of apolipoprotein A-I by chick skin. 146
The relation between plasma cholesterol and cholesterol synthesis in rats with experimental biliary obstruction. 145
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 144
Effect of heparin derived fractions on the proliferation and protein synthesis of cells in culture. 144
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. 143
Effect of prostaglandin E1 on cholesterol biosynthesis in rat liver. 142
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 142
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 142
Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS. 141
Partial duplication of the EGF precursor homology domain of the LDL receptor protein causing familial hypercholesterolemia (FH-Salerno) 141
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 141
Plasma lecithin: cholesterol acyltransferase activity in liver disease. 140
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 140
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. 138
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 137
Duplication of exons 13, 14 and 15 of the LDL-receptor gene in a patients with heterozygous familial hypercholesterolemia 137
Effect of cholesterol feeding on cholesterol biosynthesis in maternal and foetal rat liver. 137
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 134
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 134
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 134
The ultrastructure of rat plasma lipoproteins. 134
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia 133
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 133
Plasma lipoproteins, tissue cholesterol overload, and skeletal muscle apolipoprotein A-I synthesis in the developing chick. 133
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins 132
Plasma lipoproteins in rats with experimental biliary obstruction. II. An ultrastructural study. 132
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 132
The molecular basis of lecithin: Cholesterol acyltransferase deficiency syndromes: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 129
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 127
Totale 17.505
Categoria #
all - tutte 88.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.618 0 0 0 0 0 644 746 390 351 141 186 160
2020/20213.121 268 89 199 280 351 267 432 341 138 349 257 150
2021/20222.677 109 307 317 155 55 210 204 103 284 178 494 261
2022/20232.390 258 267 163 197 285 383 37 213 324 53 99 111
2023/20241.564 66 78 144 141 292 162 150 162 56 90 40 183
2024/20252.868 196 53 123 408 1.136 952 0 0 0 0 0 0
Totale 20.651